This work helps us better understand the role of FGFR2 fusion/rearrangement in patients with ICC and provides us with a new perspective on ways to personalize the treatment of ICC patients with an FGFR2 fusion/rearrangement. The gene discussed is FGFR2; the disease is intrahepatic cholangiocarcinoma.